XML 24 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 21,084 $ 4,055
Restricted cash 10 10
Available-for-sale securities - current 56,515 7,868
Research and development tax incentive receivable 2,241 715
Prepaid expenses and other current assets 3,394 1,558
Total current assets 83,244  
Property and equipment, net 562 609
Available-for-sale securities - noncurrent 10,150  
Other assets 34 30
Total assets 93,990 14,845
Current liabilities:    
Accounts payable 1,163 1,247
Accrued expenses and other payables 5,272 1,879
Total current liabilities 6,435 3,126
Redeemable convertible preferred stock tranche liability   1,643
Redeemable convertible preferred stock warrant liability   480
Total liabilities 6,435 5,249
Commitments and contingencies
Redeemable convertible preferred stock   36,996
Stockholders' equity (deficit):    
Preferred stock, $0.00001 par value, 10,000,000 and no shares authorized as of December 31, 2016 and 2015, respectively; and no shares issued and outstanding as of December 31, 2016 and 2015
Common stock, $0.00001 par value, 90,000,000 and 160,000,000 shares authorized as of December 31, 2016 and, 2015, respectively; 16,722,280 and 272,409 shares issued and outstanding as of December 31, 2016 and 2015, respectively 0 0
Additional paid-in capital 152,393 118
Accumulated other comprehensive loss (245) (102)
Accumulated deficit (64,593) (27,416)
Total stockholders' equity (deficit) 87,555 (27,400)
Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit) $ 93,990 $ 14,845